Live Price
Live Volume
Viridian Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $21.24 |
|---|---|
| Close | $21.13 |
| Low | $20.70 |
| Low Change | -0.54 (-2.54%) |
| High | $21.24 |
| High Change | +0.00 (+0.00%) |
| Range | $0.54 |
| Volume | 214.139K |
| Dollar Volume | $4.52M |
Regular Trading Hours Yesterday
| Open | $22.48 |
|---|---|
| Close | $21.23 |
| Low | $21.19 |
| Low Change | -1.30 (-5.76%) |
| High | $22.70 |
| High Change | +0.22 (+0.96%) |
| Range | $1.51 |
| Volume | 664.208K |
| Dollar Volume | $14.10M |
Premarket Yesterday
| Open | $22.15 |
|---|---|
| Close | $22.40 |
| Low | $22.15 |
| Low Change | 0.00 (0.00%) |
| High | $22.40 |
| High Change | +0.25 (+1.13%) |
| Range | $0.25 |
| Volume | 2.016K |
| Dollar Volume | $45.16K |
Viridian Therapeutics News
3 months agoinvesting.comComcast, Viridian Therapeutics jump premarket; Doximity slips
- 4 months agoinvesting.com
Viridian Therapeutics stock surges on positive trial results
- 5 months agoinvesting.com
Viridian Therapeutics stock tumbles after Amgen Tepezza data
6 months agobloomberg.comUS Premarket Movers: Alcoa, Spire, Sysco, Viridian Therapeutics
- 6 months agoinvesting.com
Viridian Therapeutics stock tumbles despite trial success
Viridian Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Viridian Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $22.48 |
|---|---|
| 10 Day Moving Average (SMA10) | $22.74 |
| 20 Day Moving Average (SMA20) | $23.32 |
| 50 Day Moving Average (SMA50) | $21.40 |
| 100 Day Moving Average (SMA100) | $18.88 |
| 200 Day Moving Average (SMA200) | $23.65 |
Viridian Therapeutics Statistics
| Average Volume (30 Days) | 1.53M |
|---|---|
| P/E Ratio (Current) | -7.56 |
| EPS (Current) | -$2.95 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$335.04M |
| Cash Ratio | 2.59 |
| Current Ratio | 16.95 |
| Quick Ratio | 16.95 |
| Debt to Equity | 0.54 |
| Enterprise Value | $2.72B |
| EV to EBITDA | -6.70 |
| EV to Sales | 38.19 |
| Price to Book | 3.81 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 35.50 |
| Return on Assets | -0.30% |
| Return on Equity | -0.50% |
Viridian Therapeutics Stock Splits
There have been 2 stock splits for Viridian Therapeutics (VRDN). The last reverse stock split occured on November 13, 2020 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Nov 13, 2020 | Reverse | 15:1 |
| Nov 7, 2016 | Reverse | 15:1 |
Viridian Therapeutics Dividends
There have been no dividends for Viridian Therapeutics (VRDN).